Decentralized
Clinical Trials (DCT)

Optimizing research with decentralized strategies

patient ipad

Decentralized, digitally enabled, direct-to-patient

Expend research to everybody

The emergence of telemedicine, mobile health applications and wearables, decentralized clinical trials are a new opportunity in the world of clinical research. DCTs, also called virtual trials, in contrast to traditional clinical trials, are built to be run remotely, without the patient having to visit the site.

FEATURES

EXPEND RESEARCH TO EVERYBODY

Flexible technologies for modern clinical trial needs

We combine unique technologies to offer an innovative DCT experience and optimize clinical research, accelerating trials and improving efficiency while leveraging a safe, scalable, and secure infrastructure.

Patient Poll

Direct Access to Patient

Patient Poll

500K+ patients | 1200+ conditions
Learn more

eCONSENT

Meet Patient Where They Are

eCONSENT

Simplify and Speed Up the Consent Process
Learn more

eCOA

Better, Faster and More Reliable Data

eCOA

Bringing Industry Leading Data Science Services With Cutting Edge Technology
Learn more

Data Science

ePRO | Biomarkers | Data linkage | Biostatistics

Data Science Expertise

ePRO | Biomarkers | Data linkage | Biostatistics
Learn more
  • Hybrid or 100% digital model (remote inclusion, monitoring vs. on-site visits)
  • Innovative Data sources and Data analysis methods

Bring treatments to market faster

Full digital CRO Services

  • DCT strategy definition
  • Study design
  • Patient recruitment
  • Software 
  • Study monitoring 
  • Biostatistics

BENEFITS

Reduce burden for participants

Fewer site visits: The ability for participants to report using an app and to collect data remotely via device reduces or eliminates the need to travel to sites.
 
Reminders and notifications: Alerts are sent directly to patients’ smartphones every day so they don’t forget about their daily responsibilities.

Improved compliance and retention

Easier participant tracking: Increased visibility of participants who are missing tasks enables a patient insights team to reach out to participants who may need greater support before they become noncompliant.

More informed and engaged participants: Improve engagement through a feedback loop that gives participants access to their own data. This helps them to feel more actively involved in their trial.

A more diverse patient panel

As DCTs remove obstacles related to distance, more patients can enroll no matter their age, ethnicity/country, comorbidities… Patients are no more too old or too far to travel to the site.

Fewer sites & fewer intermediaries

Traditional studies rely heavily on intermediaries. In DCTs,
data collection can be centralized and sometimes automated. Costs decrease, and data compilation & site-specific inconsistencies are avoided. It also means fewer submissions to review boards

Predefined and compliant data formats

All the data collected can be exported in the format required by health authorities.

Higher data quality for the sponsor

As data capture evolves from manual to digital, risks of inaccurate and missing data are avoided.

Are you interested in learning more about optimizing, decentralizing, or digitizing part or all of your clinical trial?

FREQUENTLY ASKED QUESTIONS

We define a decentralized clinical trial as a trial centered around patient needs that improves the patient experience. The focus of such a trial is on making it more convenient, closer to the patients, or both by using a combination of virtual and physical elements to conduct the required trial procedures.

Terminology and assumptions vary within the industry. However, a core concept remains consistent – decentralized clinical trials fall on a spectrum of conduct and components.

  • Traditional clinical trials encompass little to no remote or virtual elements and are conducted exclusively at brick and mortar research sites.
  • Hybrid clinical trials implement any range of decentralized, virtual, or remote components of a clinical trial.
  • Full virtual or fully remote clinical trials, operate as exclusively as possible outside of physical locations.

Decentralized can mean fully virtual or remote, or hybrid. No matter how you choose to approach or refer to decentralized clinical trials, it is important to understand the nuances of this evolving method and recognize their impact on the future of clinical research.

When executed intentionally and successfully, there are many operational, ethical, and regulatory benefits to conducting a decentralized clinical trial including:

  • Access to wider, more geographically diverse pool of participants
  • Increased participant recruitment, engagement, and retention
  • Decreased burden on trial participants
  • Stronger evidence package
  • Efficient, centralized, and timely data collection
  • Increased capacity for additional sites
  • Support for future technology and process adoption to maintain research readiness

As the industry continues to adapt to remote and virtual workflows, additional benefits will be realized.

Why should you conduct decentralized clinical trials?

When executed intentionally and successfully, there are many operational, ethical, and regulatory benefits to conducting a decentralized clinical trial including:

  • Access to wider, more geographically diverse pool of participants
  • Increased participant recruitment, engagement, and retention
  • Decreased burden on trial participants
  • Stronger evidence package
  • Efficient, centralized, and timely data collection
  • Increased capacity for additional sites
  • Support for future technology and process adoption to maintain research readiness

As the industry continues to adapt to remote and virtual workflows, additional benefits will be realized.

” By putting patients’ needs and expectations at the center of clinical trials, DCTs contribute significantly to reducing patient burden, increasing recruitment and retention rates, and shortening trial duration, thereby driving down costs. This patient-centric approach is beneficial for all stakeholders (patients, sponsors, and investigators), especially when patient insights are taken into account in optimizing the study design and selecting the trial components that will be decentralized: this is the only way to ensure patient engagement in clinical trials.” 

Lise Radoszycki

Global Senior Vice President DCT

RESOURCES

EvidentIQ and Feel Therapeutics Launch Strategic Partnership

April 5th, 2022, Hamburg (GERMANY). Today, EvidentIQ, a leading clinical data science group, announced its partnership with Feel Therapeutics, a US-based digital biomarkers and therapeutics ...

Learn More

EvidentIQ at OCT Europe in Barcelona.

We are delighted to attend the Outsourcing in Clinical Trials Europe on 4th & 5th May 2022. ...

Learn More

EvidentIQ and Feel Therapeutics Launch Strategic Partnership

April 5th, 2022, Hamburg (GERMANY). Today, EvidentIQ, a leading clinical data science group, announced its partnership with ...

Learn More

EvidentIQ and Feel Therapeutics Launch Strategic Partnership

April 5th, 2022, Hamburg (GERMANY). Today, EvidentIQ, a leading clinical data science group, announced its ...

Learn More

Get a Demo

Let us show you how we can help you and your business

Schedule a Meeting

Let’s start a new project together

Request for Proposal

Discover a solution tailored to your needs
TRUSTED BY THE WORLD'S LEADING COMPANIES